<DOC>
	<DOCNO>NCT02517151</DOCNO>
	<brief_summary>A phase 2 , randomize , placebo control trial evaluate effect n intravenous iron supplementation chronic fatigue IBD patient control disease .</brief_summary>
	<brief_title>Iron Supplementation Inflammatory Bowel Disease ( IBD ) Patients With Chronic Fatigue</brief_title>
	<detailed_description>The study evaluate 6 month therapy intravenous ferric carboxymaltose . Patients undergo 2-5 day screen period treat every 4 week iron supplementation/placebo . At every visit , hematology blood iron level evaluate . Treatment temporarily stop case either Hemoglobin level 16 g/dl ferritin 800 ng/ml ( level decrease 500 ng/ml case Transferrin-Iron Saturation Percentage 50 % ) . Study team compose blind unblinded personnel dedicate infusion device use ensure double blinding .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Diagnosis Ulcerative Colitis Crohn 's Disease establish least 6 month prior Day 1 endoscopy and/or image At least 6 month clinical remission ( Harvey Bradshaw Index ≤5 ; Mayo clinical score ≤ 2 ) Therapy mesalamine , immunosuppressor antitumor necrosis factor alpha ( TNFα ) stable dos least 3 month prior enrollment ; steroid permit 6 month prior baseline Chronic fatigue symptom ( MFI20 &gt; 13 ) Iron deficiency : ferritin &lt; 100 microg/l &lt; 300 microg/l case TransferrinIron Saturation Percentage ( TSAT ) &lt; 20 % Women childbearing potential must negative serum pregnancy test enrollment . Able willing provide write informed consent Known hypersensibility active principle excipients Pregnant lactate woman Clinically active IBD ( Harvey Bradshaw Index &gt; 6 ; Mayo clinical score &gt; 3 CReactive Protein &gt; 2.5 mg/L Renal failure ( eGFR &lt; 60 ) History adrenal insufficiency History autoimmune diseases History malignancy Depression Any current recent sign symptom viral infectious disease Recent psychotraumatic event Hemoglobin level &lt; 12.5 g/dl ( men ) &lt; 11.5 g/dL ( woman )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>iron</keyword>
	<keyword>fatigue</keyword>
	<keyword>crohn 's disease</keyword>
	<keyword>ulcerative colitis</keyword>
	<keyword>IBD</keyword>
</DOC>